SYBX
Synlogic Inc
NASDAQ: SYBX · HEALTHCARE · BIOTECHNOLOGY
$0.63
-2.93% today
Updated 2026-04-30
Market cap
$7.49M
P/E ratio
—
P/S ratio
936.86x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Synlogic Inc (SYBX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | $23.68M | $9.82M | $90.92M | $64.17M | $99.70M | $140.34M | $188.57M | $143.84M | $174.74M | $110.86M | $75.55M | $19.83M |
| Cash & equivalents | — | — | $23.18M | $9.32M | $89.71M | $16.43M | $87.03M | $11.25M | $26.18M | $32.51M | $16.44M | $15.86M | $23.96M | $18.86M |
| Current assets | — | — | $23.42M | $9.62M | $90.54M | $61.38M | $87.03M | $122.73M | $133.25M | $106.85M | $133.31M | $79.78M | $49.91M | $19.78M |
| Total liabilities | — | — | $53.60M | $57.78M | $5.90M | $3.81M | $14.66M | $16.24M | $31.67M | $28.70M | $27.47M | $28.25M | $32.90M | $7.08M |
| Current liabilities | — | — | $1.15M | $2.50M | $5.90M | $2.76M | $9.03M | $8.34M | $8.86M | $8.30M | $10.08M | $12.12M | $20.40M | $7.08M |
| Long-term debt | — | — | — | — | $0.00 | $0.00 | $466000.00 | — | — | — | — | — | — | — |
| Shareholder equity | — | — | $-29.91M | $-47.95M | $85.02M | $60.35M | $85.04M | $124.10M | $156.91M | $115.14M | $147.27M | $82.61M | $42.66M | $12.75M |
| Retained earnings | — | — | $-30.80M | $-47.95M | $-76.52M | $-102.79M | $-71.65M | $-119.77M | $-171.14M | $-230.31M | $-290.87M | $-357.02M | $-414.30M | $-441.65M |
| Accounts receivable | — | — | $195000.00 | $155000.00 | $36000.00 | — | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |